APA (7th ed.) Citation

Obeid, K., Kanellopoulos, P., Abouzayed, A., Mattsson, A., Tolmachev, V., Nock, B. A., . . . Orlova, A. (2024). GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics. Pharmaceutics, 16(4), 513. https://doi.org/10.3390/pharmaceutics16040513

Chicago Style (17th ed.) Citation

Obeid, Karim, Panagiotis Kanellopoulos, Ayman Abouzayed, Adam Mattsson, Vladimir Tolmachev, Berthold A. Nock, Theodosia Maina, and Anna Orlova. "GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics." Pharmaceutics 16, no. 4 (2024): 513. https://doi.org/10.3390/pharmaceutics16040513.

MLA (9th ed.) Citation

Obeid, Karim, et al. "GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics." Pharmaceutics, vol. 16, no. 4, 2024, p. 513, https://doi.org/10.3390/pharmaceutics16040513.